Kolexia
Seban Romain-David
Médecine nucléaire
Institut Curie
Saint-Cloud, France
96 Activités
130 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Tumeurs du poumon Métastase tumorale Mélanome Lymphomes Carcinome pulmonaire non à petites cellules Maladie de Hodgkin Carcinome pulmonaire à petites cellules COVID-19

Industries

M3 Global Research Ltd
30 collaboration(s)
Dernière en 2023
WorldOne
5 collaboration(s)
Dernière en 2021
Sandoz
3 collaboration(s)
Dernière en 2022
Kyowa Kirin
1 collaboration(s)
Dernière en 2022

Dernières activités

Integrating F-Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography with Radiation Therapy and Immunomodulation in Precision Therapy for Solid Tumors.
Cancers   27 octobre 2023
2054P Metastatic cancer patients hospitalized at initial diagnosis: When does rescue systemic therapy make sense? ONIRIS - A national, prospective study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
A common 18F-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers.
European journal of nuclear medicine and molecular imaging   26 août 2023
Clinical Utility of Pre-Therapeutic 18FFDG PET/CT Imaging for Predicting Outcomes in Breast Cancer.
Journal of clinical medicine   24 août 2023
18FFDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab.
European journal of nuclear medicine and molecular imaging   22 août 2023
PET/CT and SPECT/CT Imaging of HER2-Positive Breast Cancer.
Journal of clinical medicine   25 juillet 2023
Advances in PET/CT Imaging for Breast Cancer.
Journal of clinical medicine   07 juillet 2023
Clinical Potential of HER2 PET as a Predictive Biomarker to Guide the Use of Trastuzumab Deruxtecan in Breast Cancer Patients.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine   25 mai 2023
Total Metabolic Tumor Volume on 18F-FDG PET/CT Is a Useful Prognostic Biomarker for Patients with Extensive Small-Cell Lung Cancer Undergoing First-Line Chemo-Immunotherapy.
Cancers   10 avril 2023
68 Ga-DOTATOC PET/CT Imaging of a Muscular Solitary Fibrous Tumor.
Clinical nuclear medicine   01 mars 2023